In recent months it has emerged that the novel coronavirus—responsible for the COVID-19
pandemic—causes reduction of smell and taste in a large fraction of patients. The …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

This review deals with the relationship among nutrition, the immune system, and coronavirus
disease 2019 (COVID-19). The influence of nutrients and bioactive molecules present in …

While olfactory dysfunction associated with coronavirus disease 2019 (COVID-19) has
attracted considerable interest, few studies have tracked outcomes at serial time points or …

The acute loss of taste and smell following COVID-19 are hallmark symptoms that affect 20–
85% of patients. However, the pathophysiology and potential treatments of COVID-19 smell …

The prevalence of chemosensory dysfunction in patients with COVID-19 varies greatly
between populations. It is unclear whether such differences are due to factors at the level of …

A significant proportion of people infected with SARS-CoV-2 report a new onset of smell or
taste loss. The duration of the chemosensory impairment and predictive factors of recovery …

One of the most striking reported symptoms in CoViD-19 is loss of smell and taste. The
frequency of these impairments and their specificity as a potential central nervous system …

Background To study the outcome of fluticasone nasal sprays in smell disorders and
triamcinolone paste in taste dysfunction in a population of laboratory-confirmed SARS-CoV …

The objective of this study was to describe the epidemiology of COVID-19 in Nigeria with a
view of generating evidence to enhance planning and response strategies. A national …